{{ variable.name }}
| Type | Antidiabetic – dual GIP/GLP-1 receptor agonist (tirzepatide) | Model | 2023788-19-2 |
| Applicable Industry | Pharmaceutical manufacturing | ||
Dual GIP/GLP-1 agonist for superior glycaemic and weight control; once-weekly injectable peptide